Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation - PubMed (original) (raw)
. 1998 Oct 9;273(41):26292-4.
doi: 10.1074/jbc.273.41.26292.
Affiliations
- PMID: 9756856
- DOI: 10.1074/jbc.273.41.26292
Free article
Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
P H Jensen et al. J Biol Chem. 1998.
Free article
Abstract
The presynaptic protein alpha-synuclein has been implicated in the pathogenesis of Parkinson's disease. First, two missense mutations A30P and A53T cause inheritable early onset Parkinson's disease in some families. Secondly, alpha-synuclein is present in Lewy bodies of affected nerve cells in the predominant sporadic type of Parkinson's disease as well as in dementia with Lewy bodies. We demonstrate in the rat optic system that a portion of alpha-synuclein is carried by the vesicle-moving fast component of axonal transport and that it binds to rat brain vesicles through its amino-terminal repeat region. We find alpha-synuclein with the A30P mutation of familial Parkinson's disease devoid of vesicle-binding activity and propose that mutant alpha-synuclein may accumulate, leading to assembly into Lewy body filaments.
Similar articles
- Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA, Harper JD, Lansbury PT Jr. Conway KA, et al. Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r. Biochemistry. 2000. PMID: 10704204 - Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons.
Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, Grierson AJ, Miller CC, Davies AM, Buchman VL, Anderton BH, Hanger DP. Saha AR, et al. J Cell Sci. 2004 Mar 1;117(Pt 7):1017-24. doi: 10.1242/jcs.00967. J Cell Sci. 2004. PMID: 14996933 - The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG, Goedert M. Spillantini MG, et al. Ann N Y Acad Sci. 2000;920:16-27. doi: 10.1111/j.1749-6632.2000.tb06900.x. Ann N Y Acad Sci. 2000. PMID: 11193145 Review. - Alpha-synuclein and Parkinson's disease.
Golbe LI. Golbe LI. Adv Neurol. 2003;91:165-74. Adv Neurol. 2003. PMID: 12442675 Review. No abstract available.
Cited by
- Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo.
Mbefo MK, Fares MB, Paleologou K, Oueslati A, Yin G, Tenreiro S, Pinto M, Outeiro T, Zweckstetter M, Masliah E, Lashuel HA. Mbefo MK, et al. J Biol Chem. 2015 Apr 10;290(15):9412-27. doi: 10.1074/jbc.M114.610774. Epub 2015 Feb 5. J Biol Chem. 2015. PMID: 25657004 Free PMC article. - Interplay of α-Synuclein Oligomers and Endoplasmic Reticulum Stress in Parkinson'S Disease: Insights into Cellular Dysfunctions.
Zeng H, Liu Y, Liu X, Li J, Lu L, Xue C, Wu X, Zhang X, Zheng Z, Lu G. Zeng H, et al. Inflammation. 2024 Oct 9. doi: 10.1007/s10753-024-02156-6. Online ahead of print. Inflammation. 2024. PMID: 39382817 Review. - Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.
Schulte C, Gasser T. Schulte C, et al. Appl Clin Genet. 2011 Jun 1;4:67-80. doi: 10.2147/TACG.S11639. Print 2011. Appl Clin Genet. 2011. PMID: 23776368 Free PMC article. - "Janus-Faced" α-Synuclein: Role in Parkinson's Disease.
Ray B, Mahalakshmi AM, Tuladhar S, Bhat A, Srinivasan A, Pellegrino C, Kannan A, Bolla SR, Chidambaram SB, Sakharkar MK. Ray B, et al. Front Cell Dev Biol. 2021 May 28;9:673395. doi: 10.3389/fcell.2021.673395. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34124057 Free PMC article. Review. - Role of Lipids in the Pathogenesis of Parkinson's Disease.
Kamano S, Ozawa D, Ikenaka K, Nagai Y. Kamano S, et al. Int J Mol Sci. 2024 Aug 16;25(16):8935. doi: 10.3390/ijms25168935. Int J Mol Sci. 2024. PMID: 39201619 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical